» Articles » PMID: 1281454

Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) and Granulocyte Colony-stimulating Factor (G-CSF) Secretion by Adherent Monocytes Measured by Quantitative Immunoassays

Overview
Journal Eur J Haematol
Specialty Hematology
Date 1992 Oct 1
PMID 1281454
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The kinetics of GM-CSF and G-CSF secretion by purified adherent human monocytes were studied by quantitative immunoassays. Interleukin-1 (IL-1); 4-40 ng/ml and E. coli lipopolysaccharide (LPS); 0.1-1.00 ng/ml, were the most effective stimuli and induced dose-dependent secretion of both GM-CSF and G-CSF. Secretion of newly synthesized CSF was detectable 3-6 hours after stimulation and continued for approximately 24 h. Twenty minutes pulse exposure to LPS was sufficient to induce half maximum secretion of GM-CSF, and after 24-36 h the adherent monocytes could not be restimulated. Neither GM-CSF nor TNF could down-regulate the secretion of GM-CSF. IL-3 induced a minor secretion of GM-CSF whereas TNF, G-CSF, M-CSF and IFN-gamma were unable to induce GM-CSF secretion. In addition to LPS and IL-1, GM-CSF and to a minor degree TNF induced G-CSF secretion. Enriched T lymphocytes secreted GM-CSF, but not G-CSF, after stimulation with PHA or staphylococcal enterotoxin A (SEA), whereas LPS and IL-1 were without stimulatory effects. We also noted that enriched T lymphocytes added to LPS-stimulated adherent monocytes at ratios of 1:10 or more inhibited, in a dose-dependent fashion, GM-CSF secretion by 13-55%. These findings add new quantitative data on CSF secretion by human monocytes.

Citing Articles

Immunomodulatory dynamics in the porcine myometrium: global transcriptome analysis, including the effects of PPARγ ligands.

Kurzynska A, Mierzejewski K, Golubska M, Jastrzebski J, Bogacka I BMC Genomics. 2024; 25(1):1183.

PMID: 39639230 PMC: 11619573. DOI: 10.1186/s12864-024-11083-7.


Chitosan-Based Dressing as a Sustained Delivery System for Bioactive Cytokines.

Lewicki S, Zwolinski M, Hovagimyan A, Stelmasiak M, Szarpak L, Lewicka A Int J Mol Sci. 2024; 25(1).

PMID: 38203201 PMC: 10778940. DOI: 10.3390/ijms25010030.


Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor.

Alshari O, Al Zubi Y, Al Sharie A, Wafai F, Aleshawi A, Atawneh F Ther Clin Risk Manag. 2021; 17:963-973.

PMID: 34522100 PMC: 8435033. DOI: 10.2147/TCRM.S318370.


The role of granulocyte colony‑stimulating factor in breast cancer development: A review.

Liu L, Liu Y, Yan X, Zhou C, Xiong X Mol Med Rep. 2020; 21(5):2019-2029.

PMID: 32186767 PMC: 7115204. DOI: 10.3892/mmr.2020.11017.


Efficacy of Intrauterine Injection of Granulocyte Colony Stimulating Factor (G-CSF) on Treatment of Unexplained Recurrent Miscarriage: A Pilot RCT Study.

Zafardoust S, Akhondi M, Sadeghi M, Mohammadzadeh A, Karimi A, Jouhari S J Reprod Infertil. 2017; 18(4):379-385.

PMID: 29201668 PMC: 5691254.